Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.55 million shares were traded. STTK stock price reached its highest trading level at $1.95 during the session, while it also had its lowest trading level at $1.74.
Ratios:
For a better understanding of STTK, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.25 and its Current Ratio is at 10.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Wedbush on September 08, 2025, initiated with a Outperform rating and assigned the stock a target price of $4.
On March 17, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 25 ’25 when ORBIMED ADVISORS LLC bought 6,306,127 shares for $0.87 per share. The transaction valued at 5,471,826 led to the insider holds 5,255,106 shares of the business.
Ashiya Mona bought 6,306,127 shares of STTK for $5,471,826 on Aug 25 ’25. The Director now owns 5,255,106 shares after completing the transaction at $0.87 per share. On Dec 04 ’24, another insider, Redmile Group, LLC, who serves as the Director of the company, bought 133,371 shares for $1.25 each. As a result, the insider paid 166,714 and bolstered with 5,539,724 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STTK now has a Market Capitalization of 88141920 and an Enterprise Value of 40646916. For the stock, the TTM Price-to-Sale (P/S) ratio is 38.73 while its Price-to-Book (P/B) ratio in mrq is 1.55. Its current Enterprise Value per Revenue stands at 13.563 whereas that against EBITDA is -0.666.
Stock Price History:
The Beta on a monthly basis for STTK is 1.96, which has changed by 0.23489928 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, STTK has reached a high of $2.70, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is 14.62%, while the 200-Day Moving Average is calculated to be 54.23%.
Shares Statistics:
Over the past 3-months, STTK traded about 2.23M shares per day on average, while over the past 10 days, STTK traded about 531520 shares per day. A total of 47.90M shares are outstanding, with a floating share count of 45.15M. Insiders hold about 28.51% of the company’s shares, while institutions hold 44.78% stake in the company. Shares short for STTK as of 1759190400 were 417075 with a Short Ratio of 0.19, compared to 1756425600 on 959265. Therefore, it implies a Short% of Shares Outstanding of 417075 and a Short% of Float of 1.2899999500000001.
Earnings Estimates
. The current rating of Shattuck Labs Inc (STTK) is the result of assessments by 5.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.08 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$0.51 and -$1.29 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.63, with 6.0 analysts recommending between -$0.29 and -$1.22.
